Idiopathic thrombocytopenic purpura and the drug abciximab both target platelet membrane glycoprotein IIb-IIIa. ITP is an immune destruction of platelets. Besides being impossible to pronounce, abciximab is used in patients undergoing percutaneous coronary intervention, and is an antiplatelet agent.
Amazon Now Has a Discounted Prime Membership for 'Young Adults'
-
Prime Member perks for half the price.
2 hours ago
Posts
quick question, doesnt idiopathic mean we dont know whats causing the dz? How can this be idiopathic, if we know its due to immune destruction?
ReplyDelete